Target intelligence / Profile preview

long intergenic non-protein coding RNA 293 (LINC00293)

Target
LINC00293
Molecular classification
Long non-coding RNA (lncRNA), Non-protein-coding RNA
01

Overview

Long intergenic non-protein coding RNA 293 (LINC00293) is a human long non-coding RNA (lncRNA) gene found on chromosome 8, officially named and cataloged by the HUGO Gene Nomenclature Committee[1][7]. It does not code for a protein and is involved in regulatory roles at the RNA level. Studies indicate that LINC00293 is implicated in several disease processes: it is upregulated in serum from patients with secondary and primary progressive multiple sclerosis, enriched in exosomes from endometriotic lesions, associated with spermatogonial stem cell development, used in predictive models for breast cancer relapse, and its downregulation (due to hepatitis B virus integration) correlates with poor prognosis in hepatocellular carcinoma[3]. LINC00293 is therefore of biomedical interest for its possible role as a biomarker and as a putative therapeutic target under investigation but is not currently a conventional drug target such as a receptor, enzyme, or transporter[3].

Other names
BEYLANCRNA00293LINC00293
02

Biological functions

Regulation of gene expressionCell proliferationInvolvement in disease processes (such as cancer and endometriosis)
03

Disease associations

CancerEndometriosisMultiple sclerosisHepatocellular carcinoma
04

Biomarkers

Potential biomarker for multiple sclerosis progressionbreast cancer recurrence-free survivalhepatocellular carcinoma prognosisendometriosis

Beyond the preview

Go deeper on long intergenic non-protein coding RNA 293 (LINC00293).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on long intergenic non-protein coding RNA 293 (LINC00293).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call